The
The pill is intended to treat mild-to-moderate Covid-19 in adults at risk of developing severe illness. Merck developed the treatment with partner
Merck’s
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
